Based on recent data, Vera Therapeutics, Inc. (VERA) shows an Average True Range (ATR) of 2.2 and an Enterprise Value of 2.2B. Its average trading volume over the past 3 months is 1.14M, indicating liquidity. These fundamental metrics provide insight into VERA's underlying financial health and market activity.
| ATR | 2.2 |
| Enterprise Value | 2.2B |
| Avg Vol (3 Months) | 1.14M |
| Avg Vol (10 Days) | 914.79K |
Vera Therapeutics, Inc. (VERA) technical indicators as of June 17, 2026: the SMA 20 is -1.51%, SMA 50 at -8.96%, and SMA 200 at 35.92%. The RSI 14 value is 45, suggesting its current momentum. These technical analysis signals help assess VERA's price trends and potential future movements.
| SMA 20 | -1.51% |
| SMA 50 | -8.96% |
| SMA 200 | 35.92% |
| RSI 14 | 45 |
Vera Therapeutics, Inc. (VERA) stock performance overview as of June 17, 2026: The 52-week high is $56.05 (currently -24.44% below), and the 52-week low is $19.07 (currently 128.55% above). Over the past year, VERA's performance is 36.76%, compared to the S&P 500's 9.48% change.
| 52-Week High | 56.05 |
| 52-Week High Chg | -24.44% |
| 52-Week Low | 19.07 |
| 52-Week Low Chg | +128.55% |
| S&P 500 52-Week Chg | 9.48% |
According to market data, Vera Therapeutics, Inc. (VERA) stock's recent performance metrics show that over the last month, VERA is -7.62%, with a Year-to-Date (YTD) performance of -11.47%. Over the past year, the stock has seen a 36.76% change. These figures summarize VERA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 35.29 | 39.45 | 47 | 56.05 | 56.05 | 50.84 |
| Low | 30.97 | 30.59 | 30.59 | 30.59 | 19.07 | 30.59 |
| Performance | -3.51% | -7.62% | +43.55% | +96.71% | +36.76% | -11.47% |
According to current financial data, VERA stock's P/E (TTM) ratio is -6.54, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for VERA, including P/S (N/A), P/B (4.83), and P/FCF (-8.24), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | VERA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -6.54 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 4.83 | 3.78 | 11.1 | 5.13 |
| P/FCF (TTM) | -8.24 | -6.71 | -883.02 | 29.02 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep